IMDX – insight molecular diagnostics inc. (US:NASDAQ)
Stock Stats
News
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission [Yahoo! Finance]
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Funding And GraftAssureDx Catalyst [Yahoo! Finance]
Oncocyte (NASDAQ:IMDX) had its price target raised by analysts at Lake Street Capital from $8.00 to $12.00. They now have a "buy" rating on the stock.
iMDx Announces $26.0 Million Registered Direct Offering
Form 8-K Insight Molecular Diagno For: Feb 20
Form SCHEDULE 13D/A Insight Molecular Diagno Filed by: BROADWOOD PARTNERS, L.P.
Form 4 Insight Molecular Diagno For: Feb 10 Filed by: BROADWOOD CAPITAL INC
Form 8-K Insight Molecular Diagno For: Feb 10
Form 424B5 Insight Molecular Diagno
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.